IL123094A0 - Pharmaceutical compositions containing griseofulvin for inhibiting the growth of cancers - Google Patents

Pharmaceutical compositions containing griseofulvin for inhibiting the growth of cancers

Info

Publication number
IL123094A0
IL123094A0 IL12309496A IL12309496A IL123094A0 IL 123094 A0 IL123094 A0 IL 123094A0 IL 12309496 A IL12309496 A IL 12309496A IL 12309496 A IL12309496 A IL 12309496A IL 123094 A0 IL123094 A0 IL 123094A0
Authority
IL
Israel
Prior art keywords
cancers
inhibiting
growth
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL12309496A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Priority to IL13301499A priority Critical patent/IL133014A0/xx
Publication of IL123094A0 publication Critical patent/IL123094A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12309496A 1995-08-03 1996-07-30 Pharmaceutical compositions containing griseofulvin for inhibiting the growth of cancers IL123094A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL13301499A IL133014A0 (en) 1995-08-03 1996-07-30 Pharmaceutical compositions containing griseofulvin for treating viral infections

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US183995P 1995-08-03 1995-08-03
US67418196A 1996-07-16 1996-07-16
PCT/US1996/012475 WO1997005870A2 (en) 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers

Publications (1)

Publication Number Publication Date
IL123094A0 true IL123094A0 (en) 1998-09-24

Family

ID=26669547

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12309496A IL123094A0 (en) 1995-08-03 1996-07-30 Pharmaceutical compositions containing griseofulvin for inhibiting the growth of cancers

Country Status (16)

Country Link
EP (1) EP0841914A2 (ja)
JP (1) JPH11511136A (ja)
KR (1) KR19990036137A (ja)
AR (1) AR003176A1 (ja)
AU (1) AU713031B2 (ja)
BR (1) BR9609920A (ja)
CA (1) CA2228503A1 (ja)
CZ (1) CZ30598A3 (ja)
HU (1) HUP9903506A3 (ja)
IL (1) IL123094A0 (ja)
MX (1) MX9800945A (ja)
NO (1) NO980420L (ja)
PL (1) PL324905A1 (ja)
SK (1) SK14298A3 (ja)
TR (1) TR199800244T2 (ja)
WO (1) WO1997005870A2 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1098641B1 (en) * 1998-07-27 2016-04-27 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
KR20010103655A (ko) * 1998-11-09 2001-11-23 케네쓰 제이. 울코트 키메라 항-ｃｄ２０항체를 이용한 순환성 종양세포와관련된 혈액학적 악성종양의 치료법
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
CN101816794A (zh) * 2001-06-25 2010-09-01 味之素株式会社 抗肿瘤剂
EP2008652A1 (en) * 2007-06-28 2008-12-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) * 2008-12-22 2010-07-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Also Published As

Publication number Publication date
HUP9903506A2 (hu) 2000-06-28
PL324905A1 (en) 1998-06-22
HUP9903506A3 (en) 2000-07-28
EP0841914A2 (en) 1998-05-20
CA2228503A1 (en) 1997-02-20
CZ30598A3 (cs) 1998-06-17
KR19990036137A (ko) 1999-05-25
AU6683496A (en) 1997-03-05
TR199800244T2 (xx) 1998-09-21
BR9609920A (pt) 1999-07-06
NO980420L (no) 1998-04-03
NO980420D0 (no) 1998-01-30
MX9800945A (es) 1998-04-30
SK14298A3 (en) 1998-09-09
AU713031B2 (en) 1999-11-18
WO1997005870A2 (en) 1997-02-20
AR003176A1 (es) 1998-07-08
WO1997005870A3 (en) 1997-04-17
JPH11511136A (ja) 1999-09-28

Similar Documents

Publication Publication Date Title
IL117873A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
SG49956A1 (en) Pharmaceutical compositions containing irbesartan
IL123094A0 (en) Pharmaceutical compositions containing griseofulvin for inhibiting the growth of cancers
IL116455A0 (en) Imidazole compounds and pharmaceutical compositions containing them
HUP9900391A3 (en) Pharmaceutical compositions containing rapamycins
HUP9801532A3 (en) Use of benzimidazole derivatives for producing pharmaceutical compositions for inhibiting the growth of cancers
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
IL123095A0 (en) Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers
IL116957A0 (en) Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
HUP9801883A3 (en) Piperazine-derivatives for inhibiting of farnesyl-protein transferase, preparation and use thereof, pharmaceutical compositions containing these compounds
IL122618A0 (en) Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
IL117876A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
ZA964377B (en) A pharmaceutical compositions for inhibiting the growth of cancers.
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
ZA962879B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
IL122717A0 (en) Compounds and pharmaceutical compositions containing them
ZA962916B (en) New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
ZA964374B (en) A pharmaceutical compositions for inhibiting the growth of cancers.
IL123093A0 (en) Pharmaceutical compositions containing 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers
HUP9900901A3 (en) A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
ZA962878B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
IL117656A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
ZA962880B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds